Potassium 3-thiophenetrifluoroborate
Product Information
Molecular Formula
C4H3BF3KS
Molecular Weight
190.04
Description
Potassium 3-thiophenetrifluoroborate is a valuable chemical compound used in the biomedical industry. It exhibits potential as a pharmaceutical intermediate with applications in the drug development of various diseases. Its unique properties make it an ideal component in the synthesis of drugs targeting specific enzyme inhibitors, antiviral agents, or anticancer therapies. With its versatile nature, Potassium 3-thiophenetrifluoroborate plays a vital role in advancing biomedical research and drug discovery efforts.
Synonyms
Potassium trifluoro(thiophen-3-yl)borate; Potassium Thiophene-3-trifluoroborate; potassium; trifluoro(thiophen-3-yl)boranuide; potassium trifluoro(thiophen-3-yl)boranuide; Borate(1-),trifluoro-3-thienyl-,potassium(1:1),(t-4)-; Potassiotrifluoro(3-thienyl) boron(V); AS-2393; potassium trifluoro(3-thienyl)boranuide; POTASSIUM 3-THIENYLTRIFLUOROBORATE; potassium,trifluoro(thiophen-3-yl)boranuide
IUPAC Name
potassiumtrifluoro(thiophen-3-yl)boranuide
SMILES
[B-](C1=CSC=C1)(F)(F)F.[K+]
InChI
InChI=1S/C4H3BF3S.K/c6-5(7,8)4-1-2-9-3-4/h1-3H/q-1+1
InChI Key
ULOOPHJJEPUNNH-UHFFFAOYSA-N
Flash Point
Not applicable
Safety Information
Hazards
H315 - H319 - H335
Precautionary Statement
P302 + P352 - P305 + P351 + P338
Computed Properties
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
5
Rotatable Bond Count
0
Exact Mass
189.9637674 g/mol
Monoisotopic Mass
189.9637674 g/mol
Topological Polar Surface Area
28.2Ų
Heavy Atom Count
10
Formal Charge
0
Complexity
107
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
2
Compound Is Canonicalized
Yes
Patents
| Publication Number | Title | Priority Date |
|---|---|---|
| AU-2015268962-A1 | MTH1 inhibitors for treatment of inflammatory and autoimmune conditions | 2014-06-04 |
| CA-2948601-A1 | Mth1 inhibitors for treatment of inflammatory and autoimmune conditions | 2014-06-04 |
| EP-3151833-A1 | Mth1 inhibitors for treatment of inflammatory and autoimmune conditions | 2014-06-04 |
| US-10064869-B2 | MTH1 inhibitors for treatment of inflammatory and autoimmune conditions | 2014-06-04 |
| US-10632125-B2 | MTH1 inhibitors for treatment of inflammatory and autoimmune conditions | 2014-06-04 |
| US-2017196873-A1 | Mth1 inhibitors for treatment of inflammatory and autoimmune conditions | 2014-06-04 |
| US-2019000856-A1 | Mth1 inhibitors for treatment of inflammatory and autoimmune conditions | 2014-06-04 |
| WO-2015187089-A1 | Mth1 inhibitors for treatment of inflammatory and autoimmune conditions | 2014-06-04 |
| US-2016002270-A1 | Synthesis and use of fluorinated compounds | 2013-02-12 |
| US-9856275-B2 | Synthesis and use of fluorinated compounds | 2013-02-12 |
Literatures
| PMID | Publication Date | Title | Journal |
|---|---|---|---|
| 19389044 | 2009-06-01 | Toxicological investigation and antinociceptive property of potassium thiophene-3-trifluoroborate | Basic & clinical pharmacology & toxicology |
